Skip to content

Investigation Of Laser For Eye Treatment

Clinical Investigation of the WaveLight® UV Femtosecond Laser Lenticle Extraction Sphere Nomogram

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053228
Enrollment
45
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

Intervention1: WaveLight® Ultraviolet Femtosecond Laser System, Model 1026 (UV fs-Laser) with accompanying Patient Interface, Model 1507: Preparation of the subject for surgery involves the use of a p

Sponsors

Alcon Laboratories Inc
Lead Sponsor
Alcon Laboratories Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Participants will include male and female subjects 18 years of age or older, with good ocular health, diagnosed with myopia in the study eye with manifest refraction sphere of -0.50 to -10.0 D and cylinder < -0.5 D. Subjects must have no evidence of cataract or prior ocular surgeries in the study eye.

Exclusion criteria

Exclusion criteria: Subjects will be excluded if the eye to be treated is unable to focus for imaging and/or treatment, has a predicted residual stromal bed thickness <250 µm, or if the subject has any acute or chronic disease or illness that would increase the operative risk or confound the outcomes of the study or are using any contraindicated medications

Design outcomes

Primary

MeasureTime frame
Evaluate achieved spherical manifest refraction at post operative follow up visits.Timepoint: Day 01 Week 01 Month 01 month 03 Month 06

Secondary

MeasureTime frame
Cylinder manifest refraction, UCDVA and MRSE at postoperative follow-up visitsTimepoint: Day 01 Week 01 Month 01 month 03 Month 06

Countries

Australia, Germany, India

Contacts

Public ContactDr. Arindam Dey

Alcon laboratories India Pvt Ltd

pavan-1.kumar@alcon.com9963170098

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026